Respiratory Medicine
Volume 103, Issue 8 , Pages 1224-1230, August 2009

Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD

Cardio-Thoracic and Vascular Department, University of Pisa, Italy

Received 20 August 2008; accepted 27 January 2009. published online 23 March 2009.

Summary 

Objectives

To identify predictors of success for an 8week pulmonary rehabilitation programme (PRP) in patients with chronic obstructive pulmonary disease (COPD).

Methods

Sixty patients were stratified in subgroups according to baseline findings: airway obstruction (FEV1 ≥ or <50% pred), pulmonary hyperinflation (TLC > or ≤120% pred), BMI value (BMI > or ≤25), cardiovascular (CV) comorbidity, and resting PaO2 (PaO2 ≥ or <60mmHg). Outcome measurements of PRP were: >54m increase in 6min walking test (6MWT), or >4points reduction in total score of S. George Respiratory Questionnaire (SGRQ). Logistic regression analysis was used.

Results

After PRP there was a significant improvement in exercise tolerance and quality of life, which correlated with baseline FEV1/VC, PaO2, SpO2, 6MWT and SGRQ. SGRQ significantly decreased and 6MWT significantly increased after PRP in all subgroups, except for patients with CV comorbidities. Both univariate and multivariate logistic regression analyses showed that BMI>25 and resting PaO2<60mmHg were independent predictors of PRP efficacy in terms of improvement of 6MWT, but not of SGRQ scores.

Conclusions

Clinical and functional baseline findings do not predict the response to PRP in COPD. The greater efficacy in patients with BMI>25 or with PaO2<60mmHg may be due to a greater deconditioning in overweight patients, and to a larger room for improvement in hypoxemic patients.

Keywords: COPD, Comorbities, Pulmonary rehabilitation, Predictors, 6MWT, SGRQ

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(09)00039-0

doi:10.1016/j.rmed.2009.01.023

Respiratory Medicine
Volume 103, Issue 8 , Pages 1224-1230, August 2009